Trial Profile
Visualizing beta cells in morbid obese patients with T2D before and after bariatric surgery (NL51980.091.15).
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2016
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- 09 Dec 2016 New trial record